These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20697056)

  • 1. Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine.
    Akkad W; Salem B; Freeman JW; Huntington MK
    Arch Neurol; 2010 Aug; 67(8):1018-20. PubMed ID: 20697056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H1N1 vaccine-related acute transverse myelitis.
    Korn-Lubetzki I; Dano M; Raveh D
    Isr Med Assoc J; 2011 Apr; 13(4):249-50. PubMed ID: 21598817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transverse myelitis associated with anti-influenza A (H1N1) vaccination].
    Arcondo MF; Wachs A; Zylberman M
    Medicina (B Aires); 2011; 71(2):161-4. PubMed ID: 21550934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute transverse myelitis following vaccination against H1N1 influenza: a case report.
    Gui L; Chen K; Zhang Y
    Int J Clin Exp Pathol; 2011 Mar; 4(3):312-4. PubMed ID: 21487527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction?
    Austin A; Tincani A; Kivity S; Arango MT; Shoenfeld Y
    Isr Med Assoc J; 2015 Feb; 17(2):120-2. PubMed ID: 26223092
    [No Abstract]   [Full Text] [Related]  

  • 6. A case report of transverse myelitis following influenza vaccination.
    Ambrose CS; Loop B; Miday R
    Arch Neurol; 2011 Aug; 68(8):1085; author reply 1085-6. PubMed ID: 21825251
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute transverse myelitis and acute motor axonal neuropathy developed after vaccinations against seasonal and 2009 A/H1N1 influenza.
    Sato N; Watanabe K; Ohta K; Tanaka H
    Intern Med; 2011; 50(5):503-7. PubMed ID: 21372468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transverse myelitis with Brown-Sèquard syndrome after H1N1 immunization.
    Vieira MA; Costa CH; Vieira CP; Cavalcanti Mdo A; Ferreira-Filho SP
    Arq Neuropsiquiatr; 2012 Jul; 70(7):555. PubMed ID: 22836467
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
    Stavroulopoulos A; Stamogiannos G; Aresti V
    Ren Fail; 2010; 32(9):1044-8. PubMed ID: 20863207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
    Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C
    Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
    Bolam B; Grills N
    Aust N Z J Public Health; 2009 Dec; 33(6):584. PubMed ID: 20078579
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.
    Burt D; Mallett C; Plante M; Zimmermann J; Torossian K; Fries L
    Expert Rev Vaccines; 2011 Mar; 10(3):365-75. PubMed ID: 21434804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H1N1 vaccine for prevention of pandemic influenza.
    Med Lett Drugs Ther; 2009 Oct; 51(1322):77-8. PubMed ID: 19798010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pearls for H1N1 influenza vaccination.
    Marcotte GV
    J Allergy Clin Immunol; 2010 Apr; 125(4):951-2; author reply 952. PubMed ID: 20226509
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
    Greenhawt MJ; Chernin AS; Howe L; Li JT; Sanders G
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):387-93. PubMed ID: 21055666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures and retrograde amnesia with cerebrospinal fluid changes following H1N1 influenza vaccination.
    Mitrakrishnan S; Ranjanie G; Thirunavakarasu T; Manjula C; Nayananjani K
    Vaccine; 2011 Aug; 29(37):6369-70. PubMed ID: 21840464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate.
    Kwon Y; Cho HY; Lee YK; Bae GR; Lee SG
    Vaccine; 2010 Dec; 29(2):161-5. PubMed ID: 21055495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.